Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma

Cell division cycle associated 5 (CDCA5) has been associated with the progression of several types of cancers. However, its possible role and mechanism in hepatocellular carcinoma (HCC) remain unknown. In the present study, immunohistochemical staining and real-time PCR were used to assess CDCA5 pro...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncol Rep
Asıl Yazarlar: Wang, Jianlin, Xia, Congcong, Pu, Meng, Dai, Bin, Yang, Xisheng, Shang, Runze, Yang, Zhen, Zhang, Ruohan, Tao, Kaishan, Dou, Kefeng
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: D.A. Spandidos 2018
Konular:
Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6111608/
https://ncbi.nlm.nih.gov/pubmed/30015982
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2018.6579
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller